Published in Oncogene on March 19, 2012
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Hum Mol Genet (2013) 1.87
Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma. Oncotarget (2014) 1.18
Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development. PLoS Med (2013) 1.10
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. Int J Gynecol Cancer (2016) 1.06
Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma. J Exp Clin Cancer Res (2014) 0.96
Signalling pathways in endometrial cancer. Contemp Oncol (Pozn) (2014) 0.93
Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma. PLoS One (2013) 0.92
The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium. Mod Pathol (2013) 0.91
Prognostic biomarkers in endometrial and ovarian carcinoma. Virchows Arch (2014) 0.90
Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases. Am J Cancer Res (2013) 0.89
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Mol Cancer (2014) 0.87
Molecular mechanisms of tamoxifen-associated endometrial cancer (Review). Oncol Lett (2015) 0.86
The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer. J Transl Med (2014) 0.84
PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma. Am J Cancer Res (2014) 0.80
LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells. J Biomed Sci (2015) 0.79
EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma. Oncotarget (2016) 0.79
Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication. Drug Des Devel Ther (2015) 0.79
Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma. Lab Invest (2014) 0.78
Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma. Sci Rep (2015) 0.78
Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53. Cancer (2014) 0.78
Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas. Virchows Arch (2015) 0.77
Modal variety of microsatellite instability in human endometrial carcinomas. J Cancer Res Clin Oncol (2015) 0.76
SOX17 is a tumor suppressor in endometrial cancer. Oncotarget (2016) 0.75
The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases. Front Pharmacol (2016) 0.75
MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells. PLoS One (2016) 0.75
Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers. Mod Pathol (2016) 0.75
Molecular biology of gynecological cancer. Oncol Lett (2015) 0.75
The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers. Front Pharmacol (2017) 0.75
A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium. Cell Death Differ (2017) 0.75
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst (2000) 6.38
Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol (2001) 3.80
Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol (1993) 2.74
New acrofacial dysostosis syndrome in 3 sibs. Am J Med Genet (1990) 2.63
K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer (1997) 2.60
Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol (2001) 2.55
p53 protein expression in viral warts from patients with epidermodysplasia verruciformis. Br J Dermatol (1995) 2.04
Molecular epidemiology of caliciviruses causing outbreaks and sporadic cases of acute gastroenteritis in Spain. J Clin Microbiol (2002) 1.84
Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol (2007) 1.78
Morphologic precursors of ovarian epithelial tumors. Obstet Gynecol (1993) 1.70
Changes in the long bones due to fetal immobility caused by neuromuscular disease. A radiographic and histological study. J Bone Joint Surg Am (1988) 1.64
MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer (1999) 1.63
Granulocytic sarcoma of the female genital tract: a clinicopathologic study of 11 cases. Am J Surg Pathol (1997) 1.57
beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol (1999) 1.55
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol (1999) 1.47
Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases. Cancer (1981) 1.45
561del4 defines a novel small deletion hotspot in the interferon-gamma receptor 1 chain. Clin Immunol (2002) 1.43
Echogenic focus in the gastrointestinal wall as a sign of ulceration. Gastrointest Radiol (1989) 1.40
Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines. Oncogene (2008) 1.40
Skeletal changes in fetal akinesia. Pediatr Radiol (1989) 1.38
Effects of immobilization on fetal bone development. A morphometric study in newborns with congenital neuromuscular diseases with intrauterine onset. Calcif Tissue Int (1988) 1.33
Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints. J Clin Pathol (2008) 1.31
Epithelioid sarcoma: an analysis of 22 cases indicating the prognostic significance of vascular invasion and regional lymph node metastasis. Cancer (1978) 1.30
Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. Oncogene (2007) 1.28
Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis. Oncogene (2006) 1.25
Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer (2001) 1.24
Mitochondrial membrane peroxidizability index is inversely related to maximum life span in mammals. J Lipid Res (1998) 1.23
Endometrioid stromal sarcomas of the ovary. A clinicopathologic analysis of 23 cases. Cancer (1984) 1.23
beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol (2001) 1.20
Severe axial anomalies in the oculo-auriculo-vertebral (Goldenhar) complex. Am J Med Genet (1993) 1.19
PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum Pathol (2000) 1.18
Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol (1996) 1.18
Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci U S A (1987) 1.17
Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. Hum Pathol (1998) 1.17
beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles. Br J Dermatol (2001) 1.15
Ovarian Sertoli-Leydig cell tumors with heterologous elements. I. Gastrointestinal epithelium and carcinoid: a clinicopathologic analysis of thirty-six cases. Cancer (1982) 1.14
The genomic profile of HER2-amplified breast cancers: the influence of ER status. J Pathol (2008) 1.14
Combined effect of bacteriocins on the survival of various Listeria species in broth and meat system. Curr Microbiol (2000) 1.14
Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol (2008) 1.13
Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol (1983) 1.13
Aggressive natural killer cell leukaemia/lymphoma in two patients with lethal midline granuloma. Br J Haematol (1994) 1.12
Ovarian mucinous tumors with sarcoma-like mural nodules: a report of seven cases. Cancer (1979) 1.12
Immunological capabilities of patients with atopic dermatitis. J Invest Dermatol (1966) 1.11
p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res (2001) 1.11
Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia (2004) 1.11
Thyroid paraganglioma: a clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol (1997) 1.10
Solitary fibrous tumor of the thyroid gland: report of seven cases. Am J Surg Pathol (2001) 1.10
K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients. Cancer (1998) 1.08
Epidermoid cyst of the ovary. A report of three cases with comments on histogenesis. Am J Clin Pathol (1980) 1.06
Surgical gauze pseudotumor. Am J Surg (1988) 1.05
Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS (1999) 1.05
SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. Oncogene (2012) 1.05
Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene (2006) 1.04
Low fatty acid unsaturation protects against lipid peroxidation in liver mitochondria from long-lived species: the pigeon and human case. Mech Ageing Dev (1996) 1.04
Nucleotide sequence and organization of an H2-uptake gene cluster from Rhizobium leguminosarum bv. viciae containing a rubredoxin-like gene and four additional open reading frames. J Mol Biol (1992) 1.03
Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Cancer (1995) 1.03
CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells. Oncogene (2007) 1.02
Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors. Histol Histopathol (2006) 1.02
Chromatographic evidence for Amadori product formation in rat liver aminophospholipids. Life Sci (1995) 1.01
Adrenal gland leiomyoma in a child with acquired immunodeficiency syndrome. Pediatr Pathol Lab Med (1996) 1.01
Malignant solitary fibrous tumour of the orbit: report of a case with 8 years follow-up. Eye (Lond) (2001) 0.99
Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis (1992) 0.98
Receptors of the glial cell line-derived neurotrophic factor family of neurotrophic factors signal cell survival through the phosphatidylinositol 3-kinase pathway in spinal cord motoneurons. J Neurosci (1999) 0.98
Human parathyroid hormone-related protein in ovarian small cell carcinoma. An immunohistochemical study. Cancer (1994) 0.98
Primary angiosarcoma of the ovary: a report of seven cases and review of the literature. Int J Gynecol Pathol (1997) 0.98
Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. Am J Pathol (1994) 0.97
Ovarian Sertoli-Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases. Cancer (1982) 0.97
Personalized cancer medicine and the future of pathology. Virchows Arch (2011) 0.97
Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis (1997) 0.96
Stromal tumours of the gastrointestinal tract: a clinicopathological and ploidy analysis of 33 cases. Virchows Arch (1994) 0.96
Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications. Histopathology (2008) 0.95
JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene (2008) 0.95
Proton permeability induced by polyene antibiotics. A plausible mechanism for their inhibition of maltose fermentation in yeast. FEBS Lett (1978) 0.95
Fluorescent taxoids as probes of the microtubule cytoskeleton. Cell Motil Cytoskeleton (1998) 0.95
Analysis of Ret knockin mice reveals a critical role for IKKs, but not PI 3-K, in neurotrophic factor-induced survival of sympathetic neurons. Cell Death Differ (2008) 0.95
Comparative finite element analysis of the debonding process in different concepts of cemented hip implants. Ann Biomed Eng (2010) 0.95
Elastofibrolipoma of the mediastinum. A previously undescribed benign tumor containing abnormal elastic fibers. Am J Surg Pathol (1995) 0.95
Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA. Histopathology (1998) 0.94
Molecular pathology of ovarian carcinomas. Virchows Arch (1998) 0.94